Financial Advocates Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,896
| Closed | -$724K | – | 620 |
|
|
2025
Q1 | $724K | Buy |
+34,896
| New | +$724K | 0.05% | 344 |
|
|
2022
Q1 | – | Sell |
-3,540
| Closed | -$250K | – | 732 |
|
|
2021
Q4 | $250K | Sell |
3,540
-5,464
| -61% | -$386K | 0.02% | 663 |
|
|
2021
Q3 | $673K | Buy |
9,004
+3,307
| +58% | +$247K | 0.05% | 402 |
|
|
2021
Q2 | $490K | Sell |
5,697
-3,856
| -40% | -$332K | 0.03% | 471 |
|
|
2021
Q1 | $847K | Buy |
9,553
+4,846
| +103% | +$430K | 0.06% | 349 |
|
|
2020
Q4 | $436K | Buy |
4,707
+1,326
| +39% | +$123K | 0.03% | 475 |
|
|
2020
Q3 | $216K | Buy |
+3,381
| New | +$216K | 0.02% | 550 |
|